Biblio Discovery — Demo Discovery Service

133 results for "Ho, Mitchell"

Showing 1–20 · 1.95 seconds · RSS

  1. Journal Article Full text

    Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin

    Ho, Mitchell

    BioDrugs · 2011 · English · PubMed Central

    Liver cancer is one of the most common malignancies worldwide. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics. There is an urgent need to identify molecular targets for…

  2. Journal Article Full text

    Inaugural Editorial: Searching for Magic Bullets

    Ho, Mitchell

    Antib Ther · 2018 · English · PubMed Central

  3. Journal Article Full text

    Perspectives on the development of neutralizing antibodies against SARS-CoV-2

    Ho, Mitchell

    Antib Ther · 2020 · English · PubMed Central

    SARS-CoV-2 gains entry to human cells through its spike (S) protein binding to angiotensin-converting enzyme 2 (ACE2). Therefore, the receptor binding domain (RBD) of the S protein is the primary target for neutralizing antibodies. Selection of broad-neutralizing antibodies against SARS-CoV-2 and…

  4. Journal Article Full text

    Mammalian Cell Display for Antibody Engineering

    Ho, Mitchell; Pastan, Ira

    Methods Mol Biol · 2009 · English · PubMed Central

    Antibody engineering has generally been carried out by displaying mouse or human antibodies or antibody fragments on the surface of microorganisms (phage, bacteria and yeast). We have shown that mammalian cells can be used to display single chain antibody fragments (scFvs) for affinity maturation…

  5. Journal Article Full text

    In Vitro Antibody Affinity Maturation Targeting Germline Hotspots

    Ho, Mitchell; Pastan, Ira

    Methods Mol Biol · 2009 · English · PubMed Central

    Affinity-matured antibodies can exhibit increased biological efficacy. Regardless of whether an antibody is isolated from a hybridoma or a human Fv phage library, the antibody affinity for its target may need improvement for therapeutic applications. An increased affinity may allow for a reduced…

  6. Journal Article Full text

    The role of glypican-3 in regulating Wnt in hepatocellular carcinomas

    Gao, Wei; Ho, Mitchell

    Cancer Rep · 2011 · English · PubMed Central

    Glypican-3 (GPC3) is highly expressed in human hepatocellular carcinoma (HCC) and a growing body of evidence supports the role of GPC3 in HCC pathogenesis. In this review, we discuss recent developments regarding the regulation of GPC3 in HCC and provide insight about GPC3 as a potential…

  7. Journal Article Full text

    The Role of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma: An Update

    Gauthier, Angela; Ho, Mitchell

    Hepatol Res · 2012 · English · PubMed Central

    Sorafenib is the first and only orally administered drug currently approved to treat advanced hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib therapy, including acquired drug resistance. This review provides an overview of sorafenib in the treatment of HCC on the…

  8. Journal Article Full text

    Inhibition of Cocaine Binding to the Human Dopamine Transporter by a Single Chain Anti-Idiotypic Antibody: Its Cloning, Expression and Functional Properties

    Ho, Mitchell; Segre, Mariangela

    Biochim Biophys Acta · 2003 · English · PubMed Central

    Conventional drug development for treatment of cocaine addiction is greatly hindered by the extreme difficulty in designing a selective cocaine antagonist. We employed anti-idiotypic (anti-Id) antibodies to generate cocaine antagonists. The purpose of this study was to investigate the feasibility…

  9. Journal Article Full text

    Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2beta anti-idiotypic monoclonal antibody possessing an internal image of cocaine

    Ho, Mitchell; Segre, Mariangela

    Biochim Biophys Acta · 2001 · English · PubMed Central

    We report here the cloning and sequence analysis of cDNAs encoding the variable regions of an Ab2beta anti-idiotypic monoclonal antibody (K1-4c, gamma1kappa) that mimics the configuration of cocaine. The Ab2beta specifically binds to the human dopamine transporter as shown by confocal…

  10. Journal Article Full text

    Display and selection of scFv antibodies on HEK-293T cells

    Ho, Mitchell; Pastan, Ira

    Methods Mol Biol · 2009 · English · PubMed Central

    We describe a human cell display strategy to isolate high affinity single chain antibody fragments (scFvs) specific for CD22 for the treatment of B-cell malignancies. Our strategy uses flow cytometry and human embryonic kidney 293T (HEK-293T) cells that are widely used for transient protein…

  11. Journal Article Full text

    Glypican-3: a new target for cancer immunotherapy

    Ho, Mitchell; Kim, Heungnam

    Eur J Cancer · 2010 · English · PubMed Central

    Hepatocellular carcinoma (HCC) remains a common malignant cancer worldwide. There is an urgent need to identify new molecular targets for the development of novel therapeutic approaches. Here, we review the structure, function and biology of Glypican-3 (GPC3) and its role in human cancer with a…

  12. Journal Article Full text

    Mesothelin targeted cancer immunotherapy

    Hassan, Raffit; Ho, Mitchell

    Eur J Cancer · 2007 · English · PubMed Central

    Mesothelin is a tumour differentiation antigen that is normally present on the mesothelial cells lining the pleura, peritoneum and pericardium. It is however highly expressed in several human cancers including malignant mesothelioma, pancreatic, ovarian and lung adenocarcinoma. The normal biologic…

  13. Journal Article Full text

    The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer

    Kolluri, Aarti; Ho, Mitchell

    Front Oncol · 2019 · English · PubMed Central

    Glypican-3 (GPC3) is a cell-surface glycoprotein consisting of heparan sulfate glycosaminoglycan chains and an inner protein core. It has important functions in cellular signaling including cell growth, embryogenesis, and differentiation. GPC3 has been linked to hepatocellular carcinoma and a few…

  14. Journal Article Full text

    Current Protocols in Protein Science

    Kim, Heungnam; Ho, Mitchell

    Curr Protoc Protein Sci · 2018 · English · PubMed Central

    Heparan sulfate (HS) plays an important role in development and disease. It interacts with many growth factors, chemokines and other ligands known to be important for cell growth, motility and differentiation. However, isolating an antibody to HS in mice, rabbits or humans is difficult due to the…

  15. Journal Article Full text

    DNA damaging agent-based antibody-drug conjugates for cancer therapy

    Fu, Ying; Ho, Mitchell

    Antib Ther · 2018 · English · PubMed Central

    Currently, four antibody-drug conjugates (ADCs) are approved by the Food and Drug Administration or the European Medicine Agency to treat cancer patients. More than 60 ADCs are in clinical development for cancer therapy. More than 60% of ADCs in clinical trials employ microtubule inhibitors as…

  16. Journal Article Full text

    Role of glypican-1 in regulating multiple cellular signaling pathways

    Pan, Jiajia; Ho, Mitchell

    Am J Physiol Cell Physiol · 2021 · English · PubMed Central

    Glypican-1 (GPC1) is one of the six glypican family members in humans. It is composed of a core protein with three heparan sulfate chains and attached to the cell membrane by a glycosyl-phosphatidylinositol anchor. GPC1 modulates various signaling pathways including fibroblast growth factors (FGF)…

  17. Journal Article Full text

    A novel IgM intranasal intervention against SARS-CoV-2

    Yerabham, Antony; Ho, Mitchell

    Antib Ther · 2021 · English · PubMed Central

  18. Journal Article Full text

    T cell receptor mimic antibodies for cancer immunotherapy

    Duan, Zhijian; Ho, Mitchell

    Mol Cancer Ther · 2021 · English · PubMed Central

    Antibody-based immunotherapies show clinical effectiveness in various cancer types. However, the target repertoire is limited to surface or soluble antigens which are a relatively small percentage of the cancer proteome. Most proteins of the human proteome are intracellular. Short peptides from…

  19. Journal Article Full text

    Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic

    Sun, Yaping; Ho, Mitchell

    Antib Ther · 2020 · English · PubMed Central

    SARS-CoV-2 antibody therapeutics are being evaluated in clinical and preclinical stages. As of 11 October 2020, 13 human monoclonal antibodies targeting the SARS-CoV-2 spike protein have entered clinical trials with three (REGN-COV2, LY3819253/LY-CoV555, and VIR-7831/VIR-7832) in phase 3. On 9…